Evidence map›Paper›PMID 22923379›Full record

ArticleGenetics2012

Rapid profiling of disease alleles using a tunable reporter of protein misfolding.

Adrianne M C Pittman, Melissa D Lage, Vladimir Poltoratsky, Justin D Vrana, Alessandro Paiardini, Alessandro Roncador, Barbara Cellini, Robert M Hughes, Chandra L Tucker

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Intra-Frontiers in genetics · 2023
    Article
  2. Article
  3. A molecular imaging biosensor detects in vivo protein folding and misfolding.Journal of molecular medicine (Berlin, Germany) · 2016
    Article
  4. Article
  5. Benchmarking of optical dimerizer systems.ACS synthetic biology · 2014
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Disease genetics: reporting on stability.Nature reviews. Genetics · 2012
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Adrianne M C PittmanDepartment of Biology, Duke University, Durham, North Carolina 27708, USA.
Melissa D Lage
Vladimir Poltoratsky
Justin D Vrana
Alessandro Paiardini
Alessandro Roncador
Barbara Cellini
Robert M Hughes
Chandra L Tucker
Duke University · USUniversity of Colorado Denver · USUniversity of Verona · ITSapienza University of Rome · IT

Funding

Analysis of PH1-associated alanine:glyoxylate aminotranferase (AGT) using yeastR01DK081584 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI TUCKER, CHANDRA L · 2008 to 2011
$1.5M
Identification of pharmacological chaperones for misfolded proteinsR21DK075291 · NIDDK · DUKE UNIVERSITY · PI TUCKER, CHANDRA L · 2008 to 2009
$281k
NIDDK NIH HHS R01 DK081584NIDDK NIH HHS R01DK81584NIDDK NIH HHS R21 DK075291NIDDK NIH HHS R21DK075291Telethon GGP10092
6 · The paper itself

Abstract

Many human diseases are caused by genetic mutations that decrease protein stability. Such mutations may not specifically affect an active site, but can alter protein folding, abundance, or localization. Here we describe a high-throughput cell-based stability assay, IDESA (intra-DHFR enzyme stability assay), where stability is coupled to cell proliferation in the model yeast, Saccharomyces cerevisiae. The assay requires no prior knowledge of a protein's structure or activity, allowing the assessment of stability of proteins that have unknown or difficult to characterize activities, and we demonstrate use with a range of disease-relevant targets, including human alanine:glyoxylate aminotransferase (AGT), superoxide dismutase (SOD-1), DJ-1, p53, and SMN1. The assay can be carried out on hundreds of disease alleles in parallel or used to identify stabilizing small molecules (pharmacological chaperones) for unstable alleles. As demonstration of the general utility of this assay, we analyze stability of disease alleles of AGT, deficiency of which results in the kidney stone disease, primary hyperoxaluria type I, identifying mutations that specifically affect the protein-active site chemistry.

Indexed as

AllelesGenes, ReporterHigh-Throughput Screening AssaysProtein FoldingDrug Evaluation, PreclinicalEnzyme StabilityGenetic Association StudiesHumansModels, MolecularProtein ConformationReproducibility of ResultsSaccharomyces cerevisiaeSensitivity and SpecificityTransaminasesTransaminases

Identifiers

PMID22923379
PMCPMC3522161
OpenAlexW2100418719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.